Yuan Zhi
Stock Analyst at B. Riley Securities
(1.78)
# 3,264
Out of 4,964 analysts
27
Total ratings
34.62%
Success rate
-6.25%
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIR Mirion Technologies | Reiterates: Buy | $17 → $22 | $20.86 | +5.47% | 3 | Jul 23, 2025 | |
| TOI The Oncology Institute | Initiates: Buy | $6 | $3.48 | +72.41% | 1 | Jul 16, 2025 | |
| CATX Perspective Therapeutics | Maintains: Buy | $9 → $12 | $3.38 | +255.03% | 3 | Jun 23, 2025 | |
| RDNT RadNet | Initiates: Buy | $69 | $71.79 | -3.89% | 1 | Jun 13, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.2 → $1 | $1.24 | -19.03% | 2 | May 15, 2025 | |
| RADX Radiopharm Theranostics | Initiates: Buy | $15 | $5.69 | +163.63% | 1 | Mar 12, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $16 → $8 | $6.82 | +17.30% | 2 | Nov 11, 2024 | |
| AGEN Agenus | Maintains: Buy | $42 → $18 | $4.25 | +323.53% | 2 | Aug 14, 2024 | |
| CYRX Cryoport | Upgrades: Buy | $19 → $15 | $8.69 | +72.61% | 4 | Jul 31, 2024 | |
| CTSO Cytosorbents | Reiterates: Buy | $3 | $0.94 | +219.15% | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $79 | $29.92 | +164.04% | 3 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $16 | $1.74 | +819.54% | 4 | Dec 11, 2023 |
Mirion Technologies
Jul 23, 2025
Reiterates: Buy
Price Target: $17 → $22
Current: $20.86
Upside: +5.47%
The Oncology Institute
Jul 16, 2025
Initiates: Buy
Price Target: $6
Current: $3.48
Upside: +72.41%
Perspective Therapeutics
Jun 23, 2025
Maintains: Buy
Price Target: $9 → $12
Current: $3.38
Upside: +255.03%
RadNet
Jun 13, 2025
Initiates: Buy
Price Target: $69
Current: $71.79
Upside: -3.89%
Hyperfine
May 15, 2025
Maintains: Buy
Price Target: $1.2 → $1
Current: $1.24
Upside: -19.03%
Radiopharm Theranostics
Mar 12, 2025
Initiates: Buy
Price Target: $15
Current: $5.69
Upside: +163.63%
Tango Therapeutics
Nov 11, 2024
Maintains: Buy
Price Target: $16 → $8
Current: $6.82
Upside: +17.30%
Agenus
Aug 14, 2024
Maintains: Buy
Price Target: $42 → $18
Current: $4.25
Upside: +323.53%
Cryoport
Jul 31, 2024
Upgrades: Buy
Price Target: $19 → $15
Current: $8.69
Upside: +72.61%
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $0.94
Upside: +219.15%
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $29.92
Upside: +164.04%
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $1.74
Upside: +819.54%